在加拿大各省份消除型肝炎病毒的时间表
Jordan J Feld1, Marina B Klein2, Yasmine Rahal3
1Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Canadian liver journal
|December 25, 2023
概括
加拿大正在落后于消除型肝炎的目标. 三个省份需要增加年度治疗,以实现2030年目标,避免严重的健康和经济负担.
科学领域:
- 公共卫生 公共卫生
- 传染病流行病学 传染病流行病学
- 卫生经济学 卫生经济学
背景情况:
- 慢性型肝炎病毒感染仍然是全球卫生挑战.
- 加拿大此前正准备实现世界卫生组织的消除目标.
- 最近加拿大各省C型肝炎诊断和治疗率的下降早于COVID-19大流行.
研究的目的:
- 评估每一个加拿大省份C型肝炎消除的预计时间表.
- 确定不同治疗和诊断趋势对消除目标的影响.
- 量化必要的年度处理和相关的经济负担,以实现消除.
主要方法:
- 之前开发的C型肝炎的疾病和经济负担模型与当前的加拿大数据进行了更新.
- 模拟了五种不同的情景,包括现状,年均下降10%和20%,年均增长10%,以及流行后的无复苏情景.
- 关键结果包括消除的年份,每年需要的治疗,以及每省预计的疾病和经济成本.
主要成果:
- 如果没有干预,曼尼托巴,安大略省和北克预计将错过2030年型肝炎消除目标.
- 这三个省份将分别需要540次,7700次和2800次额外的年度治疗,才能按计划消除.
- 在这些省份实现及时消除可能会避免170人死亡,并节省12.266亿加元的直接医疗费用.
结论:
- 在加拿大三个省份,包括两个人口最多的省份,C型肝炎的消除面临风险.
- 紧急实施加强预防,检测和治疗策略至关重要.
- 需要创新的框架来加速实现国家型肝炎消除目标的进展.
相关概念视频
Drug Elimination: Non-Renal Routes
2.3K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.3K
Kinetics of Drug Elimination
3.4K
Eliminating drugs from the body is a vital process that occurs through excretion or metabolism. Understanding the kinetics of drug elimination is crucial for drug development, dosage determination, and optimizing patient outcomes.
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
3.4K
Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K
Drug Elimination: The Concept of Clearance
2.7K
Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
2.7K
Retrovirus Life Cycles
46.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.0K
Hepatic Drug Clearance: Role of Transporters
60
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
60


